A detailed history of Walleye Capital LLC transactions in Biote Corp. stock. As of the latest transaction made, Walleye Capital LLC holds 51,511 shares of BTMD stock, worth $268,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,511
Previous 10,667 382.9%
Holding current value
$268,372
Previous $61,000 529.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $222,191 - $305,104
40,844 Added 382.9%
51,511 $384,000
Q1 2024

May 15, 2024

BUY
$3.79 - $6.91 $40,427 - $73,708
10,667 New
10,667 $61,000
Q2 2023

Aug 14, 2023

BUY
$5.27 - $6.9 $55,472 - $72,629
10,526 New
10,526 $71,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $39.5M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.